Stimulant side effects and inverted-U: implications for ADHD guidelines

Aust N Z J Psychiatry. 2013 Mar;47(3):217-21. doi: 10.1177/0004867412450754. Epub 2012 Jun 11.

Abstract

Objective: To review literature relevant to a possible prediction of stimulant side effects in attention deficit hyperactivity disorder (ADHD), with implications for guidelines.

Method: Recent literature on inverted-U effects of dopamine in the prefrontal cortex (PFC), default mode processing, and motor circuits relevant to stimulant side effects is reviewed.

Results: The literature on inverted-U effects in the PFC suggests that catechol-O-methyltransferase (COMT) Met versus Val polymorphisms may predict excess dopaminergic effects, including headache and introversion in Met/Met subjects, but therapeutic effects in Val/Val subjects, while dopamine transporter polymorphisms may predict motor side effects. In particular, an understanding of 'inverted-U' effects helps to explain why some children may experience side effects while others show improvements at similar dose ranges.

Conclusion: Genetic prediction of stimulant side effects should be investigated, particularly given recent controversies in relation to National Health and Medical Research Council guidelines for stimulant use. A better understanding of treatment-emergent effects will also provide a better understanding of therapeutic effects.

Publication types

  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / genetics
  • Catechol O-Methyltransferase / genetics
  • Central Nervous System Stimulants / adverse effects*
  • Dopamine Plasma Membrane Transport Proteins / genetics
  • Guidelines as Topic
  • Humans
  • Polymorphism, Genetic
  • Prefrontal Cortex / drug effects*
  • Tic Disorders / chemically induced
  • Tic Disorders / genetics

Substances

  • Central Nervous System Stimulants
  • Dopamine Plasma Membrane Transport Proteins
  • Catechol O-Methyltransferase